Atea Pharmaceuticals's market cap is currently $230.14M. The company's EPS TTM is $-0.44; its P/E ratio is ―; Atea Pharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
